Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

A 4-year-old girl was diagnosed with erythrokeratodermia variabilis after other treatments failed.

Children with Parry Romberg Syndrome had successful facial fat-grafting surgeries after disease stabilization with no complications.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Hair camouflage offers various options for hair loss, helping reduce psychological impact.

Various hair camouflage options help people with hair loss improve appearance.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Mesalazine may help treat extensive alopecia areata effectively.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Baricitinib is effective for severe alopecia areata but has some side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Baricitinib may effectively treat nail changes in alopecia areata.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.